219 related articles for article (PubMed ID: 23040008)
41. Isolation of a VIM-1 metallo-β-lactamase-producing Klebsiella pneumoniae isolate in Denmark.
Hasman H; Fjeldsøe-Nielsen H; Lausten T; Berthelsen BG
Int J Antimicrob Agents; 2010 Nov; 36(5):468-9. PubMed ID: 20724117
[No Abstract] [Full Text] [Related]
42. Extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.
Shanthi M; Sekar U
J Assoc Physicians India; 2010 Dec; 58 Suppl():41-4. PubMed ID: 21568008
[TBL] [Abstract][Full Text] [Related]
43. Emergence of NDM-1-producing Klebsiella pneumoniae in Guatemala.
Pasteran F; Albornoz E; Faccone D; Gomez S; Valenzuela C; Morales M; Estrada P; Valenzuela L; Matheu J; Guerriero L; Arbizú E; Calderón Y; Ramon-Pardo P; Corso A
J Antimicrob Chemother; 2012 Jul; 67(7):1795-7. PubMed ID: 22461309
[No Abstract] [Full Text] [Related]
44. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing KPC-2 carbapenemase in Belgium.
Bogaerts P; Montesinos I; Rodriguez-Villalobos H; Blairon L; Deplano A; Glupczynski Y
J Antimicrob Chemother; 2010 Feb; 65(2):361-2. PubMed ID: 20008447
[No Abstract] [Full Text] [Related]
45. Klebsiella pneumoniae co-producing NDM-7 and OXA-48 carbapenemases isolated from a patient with prolonged hospitalisation.
Lázaro-Perona F; Sarria-Visa A; Ruiz-Carrascoso G; Mingorance J; García-Rodríguez J; Gómez-Gil R
Int J Antimicrob Agents; 2017 Jan; 49(1):112-113. PubMed ID: 27817973
[No Abstract] [Full Text] [Related]
46. Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss.
Gülmez D; Woodford N; Palepou MF; Mushtaq S; Metan G; Yakupogullari Y; Kocagoz S; Uzun O; Hascelik G; Livermore DM
Int J Antimicrob Agents; 2008 Jun; 31(6):523-6. PubMed ID: 18339523
[TBL] [Abstract][Full Text] [Related]
47. Carbapenem resistance among Escherichia coli and Klebsiella pneumoniae in a tertiary care hospital in south India.
Nagaraj S; Chandran SP; Shamanna P; Macaden R
Indian J Med Microbiol; 2012; 30(1):93-5. PubMed ID: 22361769
[TBL] [Abstract][Full Text] [Related]
48. [Epidemiological study on extended-spectrum beta-lactamase-producing in clinical isolates and selection of antibacterial drugs in China ].
Yu YS
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1918-20. PubMed ID: 15631810
[No Abstract] [Full Text] [Related]
49. Extended-spectrum β-lactamases in Escherichia coli and Klebsiella pneumoniae over 18 years: effect of different systems for eliminating duplicates.
Noguera O; López-Riquelme N; Rodríguez JC; Santibañez M; Alvarez L; Galiana A; Ruiz-García M; López-García P; Royo G
Int J Antimicrob Agents; 2012 Aug; 40(2):189-90. PubMed ID: 22727771
[No Abstract] [Full Text] [Related]
50. Emergence of Klebsiella pneumoniae of a novel sequence type (ST383) producing VIM-4, KPC-2 and CMY-4 β-lactamases.
Papagiannitsis CC; Giakkoupi P; Vatopoulos AC; Tryfinopoulou K; Miriagou V; Tzouvelekis LS
Int J Antimicrob Agents; 2010 Dec; 36(6):573-4. PubMed ID: 20863669
[No Abstract] [Full Text] [Related]
51. Importation of OXA-48-producing Klebsiella pneumoniae from Kuwait.
Poirel L; Carbonnelle E; Bernabeu S; Gutmann L; Rotimi V; Nordmann P
J Antimicrob Chemother; 2012 Aug; 67(8):2051-2. PubMed ID: 22577102
[No Abstract] [Full Text] [Related]
52. Genetic characterisation of CTX-M-15-producing Klebsiella pneumoniae and Escherichia coli strains isolated from stem cell transplant patients in Tunisia.
Abbassi MS; Torres C; Achour W; Vinué L; Sáenz Y; Costa D; Bouchami O; Ben Hassen A
Int J Antimicrob Agents; 2008 Oct; 32(4):308-14. PubMed ID: 18620848
[TBL] [Abstract][Full Text] [Related]
53. High prevalence of extended-spectrum beta-lactamases and plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae isolated from long-term care facilities in Korea.
Yoo JS; Byeon J; Yang J; Yoo JI; Chung GT; Lee YS
Diagn Microbiol Infect Dis; 2010 Jul; 67(3):261-5. PubMed ID: 20462727
[TBL] [Abstract][Full Text] [Related]
54. Emergence of an extensively drug-resistant ArmA- and KPC-2-producing ST101 Klebsiella pneumoniae clone in Italy.
Mezzatesta ML; Gona F; Caio C; Adembri C; Dell'utri P; Santagati M; Stefani S
J Antimicrob Chemother; 2013 Aug; 68(8):1932-4. PubMed ID: 23667172
[No Abstract] [Full Text] [Related]
55. The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide.
Nordmann P; Poirel L
Clin Microbiol Infect; 2014 Sep; 20(9):821-30. PubMed ID: 24930781
[TBL] [Abstract][Full Text] [Related]
56. The emergence of a novel ceftazidime-resistant CTX-M extended-spectrum beta-lactamase, CTX-M-55, in both community-onset and hospital-acquired infections in Thailand.
Kiratisin P; Apisarnthanarak A; Saifon P; Laesripa C; Kitphati R; Mundy LM
Diagn Microbiol Infect Dis; 2007 Jul; 58(3):349-55. PubMed ID: 17449211
[TBL] [Abstract][Full Text] [Related]
57. The DiversiLab system versus pulsed-field gel electrophoresis: characterisation of extended spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae.
Brolund A; Hæggman S; Edquist PJ; Gezelius L; Olsson-Liljequist B; Wisell KT; Giske CG
J Microbiol Methods; 2010 Nov; 83(2):224-30. PubMed ID: 20849889
[TBL] [Abstract][Full Text] [Related]
58. Emergence of Klebsiella pneumoniae co-producing NDM-type and OXA-181 carbapenemases.
Balm MN; La MV; Krishnan P; Jureen R; Lin RT; Teo JW
Clin Microbiol Infect; 2013 Sep; 19(9):E421-3. PubMed ID: 23668475
[TBL] [Abstract][Full Text] [Related]
59. Molecular epidemiology of OXA-48-producing Klebsiella pneumoniae in France.
Liapis E; Pantel A; Robert J; Nicolas-Chanoine MH; Cavalié L; van der Mee-Marquet N; de Champs C; Aissa N; Eloy C; Blanc V; Guyeux C; Hocquet D; Lavigne JP; Bertrand X;
Clin Microbiol Infect; 2014 Dec; 20(12):O1121-3. PubMed ID: 24942039
[TBL] [Abstract][Full Text] [Related]
60. A Long-Term Study of the Diversity of OXA-48-Like Carbapenemase-Producing Bacterial Strains in Infected Patients and Carriers.
Woerther PL; Jardak T; Ben Hassine I; Forget S; Chachaty E; Arlet G; Decré D
Microb Drug Resist; 2018 Mar; 24(2):181-189. PubMed ID: 28708476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
